The USFDA has embraced podcasting in addition to its traditional print- and Web-based public health advisories (PHAs) in order to broaden and speed up its ongoing communications concerning the safety of marketed medications when unexpected adverse events are reported to FDA.
Healthcare professionals and consumers can subscribe to these podcasts for free.
According to Andrew C. von Eschenbach, M.D., Commissioner of Food and Drugs:
"FDA's highest priority is to protect and enhance the health of the American public.
The service contributes to this goal by providing a new venue for busy health care professionals and patients to find drug safety information, so that they don't have to look for it on FDA's Web site or read about it in print.
Timely and widely available broadcasts about previously unknown potential drug risks should help ensure that these products are used safely and effectively."
Find more details from the full report.
.jpg)
Comment Preview